Literature DB >> 15674092

Correlation of alcohol consumption with liver histological features in non-cirrhotic patients.

Loreta A Kondili1, Gloria Taliani, Gojart Cerga, Maria E Tosti, Adriana Babameto, Bashkim Resuli.   

Abstract

BACKGROUND AND AIMS: The association between alcohol consumption and the risk of liver disease remains unclear. The aim of our study was to determine liver morphological features directly related to the mean lifetime daily alcohol intake (LTDAI) in non-cirrhotic patients.
METHODS: Medical records of all consecutive patients who reported alcohol consumption up to the time of hospital admission and who had undergone a liver biopsy in the Gastroenterology Unit of the University Hospital Centre of Tirana (Albania), were reviewed. Patients with established cirrhosis and/or with other possible causes of liver damage were excluded by the study.
RESULTS: The histological features revealed in the biopsy samples of 51 non-cirrhotic patients were: steatosis in 46 patients (91%), six of whom (13%) showed also alcoholic foamy degeneration; alteration of hepatocytes in 40 patients (78%), diffuse mononuclear inflammation in 37 patients (73%), polymorphonuclear inflammation in 11 patients (22%) and perivenular fibrosis in 18 patients (35%). Diffuse steatosis was directly correlated with alcohol consumption (P<0.01). No association was found between alcohol consumption and the presence of degenerative alterations of hepatocytes, Mallory bodies or hepatocellular necrosis. Fibrosis was more prevalent in patients who reported a LTDAI > or = 80 g in comparison with patients who reported a LTDAI > or = 40 to <80 g (48% vs 25%; P<0.05).
CONCLUSION: In non-cirrhotic patients liver steatosis and fibrosis were more common features among patients who reported a higher alcoholic consumption, but no clear-cut association between typical histological features of alcoholic liver disease and alcohol consumption was found.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15674092     DOI: 10.1097/00042737-200502000-00005

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  6 in total

Review 1.  Outpatient management of alcohol-related liver disease.

Authors:  Douglas A Simonetto; Vijay H Shah; Patrick S Kamath
Journal:  Lancet Gastroenterol Hepatol       Date:  2020-05

2.  Thyroid Hormone and Alcoholic Fatty Liver: The Developmental Input.

Authors:  Arturo Hernandez
Journal:  Alcohol Clin Exp Res       Date:  2019-07-24       Impact factor: 3.455

3.  Biphasic effect of alcohol intake on the development of fatty liver disease.

Authors:  Hirokazu Takahashi; Masafumi Ono; Hideyuki Hyogo; Chika Tsuji; Yoichiro Kitajima; Naofumi Ono; Takahisa Eguchi; Kazuma Fujimoto; Kazuaki Chayama; Toshiji Saibara; Keizo Anzai; Yuichiro Eguchi
Journal:  J Gastroenterol       Date:  2015-03-03       Impact factor: 7.527

Review 4.  Alcohol and fat promote steatohepatitis: a critical role for fat-specific protein 27/CIDEC.

Authors:  Suthat Liangpunsakul; Bin Gao
Journal:  J Investig Med       Date:  2016-06-24       Impact factor: 2.895

5.  Hepatic Inactivation of the Type 2 Deiodinase Confers Resistance to Alcoholic Liver Steatosis.

Authors:  Tatiana L Fonseca; Gustavo W Fernandes; Barbara M L C Bocco; Ali Keshavarzian; Shriram Jakate; Terrence M Donohue; Balázs Gereben; Antonio C Bianco
Journal:  Alcohol Clin Exp Res       Date:  2019-04-26       Impact factor: 3.928

6.  Analyzing the Spatiotemporal Distribution and Characteristics of Liver Cirrhosis in Hospitalized Patients in Wuwei, Gansu Province During 1995-2016: A Long-Term Retrospective Study.

Authors:  Yang Zhang; Ting Fu; Xiao-Jie Yuan; Yan-Cheng Ye; Zhi-Wen Guo; Kun Liu; Zhao-Hua Ji; Zhong-Jun Shao
Journal:  Front Physiol       Date:  2022-03-22       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.